![](/img/cover-not-exists.png)
Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis
Cromwell, Ian, van der Hoek, Kimberly, Melosky, Barbara, Peacock, StuartVolume:
6
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31822f657a
Date:
December, 2011
File:
PDF, 380 KB
english, 2011